Stay informed with the latest litigation news. Explore now

Patent Oppositions in medicinal compounds for specific treatments industry

Explore the competitive field of medicinal compounds for specific treatments where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medicinal compounds for specific treatments technology and learn how to protect your intellectual property.

Get Patent Opposition Report for medicinal compounds for specific treatments

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Sep 11, 2025
CompanyTotal Oppositions
NOVARTIS286
BOEHRINGER INGELHEIM107
AMGEN81
PFIZER75
NOVO NORDISK75
NESTLE62
NUTRICIA59
NESTEC54
JANSSEN PHARMACEUTICA53
BRISTOL MYERS SQUIBB47

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medicinal compounds for specific treatments industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medicinal compounds for specific treatments industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the medicinal compounds for specific treatments industry

Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 27, 2025DR REDDYS LABORATORIES
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 10, 2025ADALVO
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 7, 2025GENERICS UK
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025WUESTHOFF & WUESTHOFF
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025STADA ARZNEIMITTEL
Methods Of Making Chimeric Antigen Receptor -Expressing CellsTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAAug 1, 2025STRAWMAN
Methods For Improving Safety Of Blood-Brain Barrier TransportF HOFFMANN LA ROCHEJul 30, 2025ZWICKER SCHNAPPAUF & PARTNER
Nutritional ProductUCL BUSINESSJul 29, 2025MOLNIA
Conjugate Of Galnac And Saponin, Therapeutic Composition Comprising Said Conjugate And A Galnac-Oligonucleotide ConjugateSAPREMEJul 29, 2025STRAWMAN
Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated FatigueBHMEKEJul 29, 2025LANGE

To stay ahead in the competitive medicinal compounds for specific treatments industry, companies are constantly innovating. Here are the top patents facing oppositions in the medicinal compounds for specific treatments industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS16
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND12